These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28112516)

  • 1. Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.
    Risinger AL; Li J; Du L; Benavides R; Robles AJ; Cichewicz RH; Kuhn JG; Mooberry SL
    J Nat Prod; 2017 Feb; 80(2):409-414. PubMed ID: 28112516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.
    Li J; Risinger AL; Peng J; Chen Z; Hu L; Mooberry SL
    J Am Chem Soc; 2011 Nov; 133(47):19064-7. PubMed ID: 22040100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
    Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
    Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taccalonolide microtubule stabilizers.
    Li J; Risinger AL; Mooberry SL
    Bioorg Med Chem; 2014 Sep; 22(18):5091-6. PubMed ID: 24491636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taccalonolide Microtubule Stabilizers.
    Yee SS; Du L; Risinger AL
    Prog Chem Org Nat Prod; 2020; 112():183-206. PubMed ID: 33306174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
    Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
    Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taccalonolide Microtubule Stabilizers Generated Using Semisynthesis Define the Effects of Mono Acyloxy Moieties at C-7 or C-15 and Disubstitutions at C-7 and C-25.
    Ola ARB; Risinger AL; Du L; Zammiello CL; Peng J; Cichewicz RH; Mooberry SL
    J Nat Prod; 2018 Mar; 81(3):579-593. PubMed ID: 29360362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and biological activities of new taccalonolide microtubule stabilizers.
    Peng J; Risinger AL; Fest GA; Jackson EM; Helms G; Polin LA; Mooberry SL
    J Med Chem; 2011 Sep; 54(17):6117-24. PubMed ID: 21800839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis reactions of the taccalonolides reveal structure-activity relationships.
    Li J; Peng J; Risinger AL; Mooberry SL
    J Nat Prod; 2013 Jul; 76(7):1369-75. PubMed ID: 23855953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.
    Du L; Risinger AL; Yee SS; Ola ARB; Zammiello CL; Cichewicz RH; Mooberry SL
    J Nat Prod; 2019 Mar; 82(3):583-588. PubMed ID: 30799622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic reactions with rare taccalonolides reveal the value of C-22,23 epoxidation for microtubule stabilizing potency.
    Peng J; Risinger AL; Li J; Mooberry SL
    J Med Chem; 2014 Jul; 57(14):6141-9. PubMed ID: 24959756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taccalonolides: Novel microtubule stabilizers with clinical potential.
    Risinger AL; Mooberry SL
    Cancer Lett; 2010 May; 291(1):14-9. PubMed ID: 19880245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach.
    Du L; Yee SS; Ramachandran K; Risinger AL
    Nat Commun; 2020 Jan; 11(1):654. PubMed ID: 32005831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taccalonolide C-6 Analogues, Including Paclitaxel Hybrids, Demonstrate Improved Microtubule Polymerizing Activities.
    Risinger AL; Hastings SD; Du L
    J Nat Prod; 2021 Jun; 84(6):1799-1805. PubMed ID: 34110822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taccalonolides: A Novel Class of Microtubule-Stabilizing Anticancer Agents.
    Chen X; Winstead A; Yu H; Peng J
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of microtubule stabilization by taccalonolide AJ.
    Wang Y; Yu Y; Li GB; Li SA; Wu C; Gigant B; Qin W; Chen H; Wu Y; Chen Q; Yang J
    Nat Commun; 2017 Jun; 8():15787. PubMed ID: 28585532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation.
    Risinger AL; Riffle SM; Lopus M; Jordan MA; Wilson L; Mooberry SL
    Mol Cancer; 2014 Feb; 13():41. PubMed ID: 24576146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.
    Risinger AL; Jackson EM; Polin LA; Helms GL; LeBoeuf DA; Joe PA; Hopper-Borge E; Ludueña RF; Kruh GD; Mooberry SL
    Cancer Res; 2008 Nov; 68(21):8881-8. PubMed ID: 18974132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Taccalonolide AJ-Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Treatment of Clear Cell Renal-Cell Carcinoma.
    Han J; Zhang S; Niu J; Zhang C; Dai W; Wu Y; Hu L
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
    Risinger AL; Mooberry SL
    Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.